The impact of single gene testing (SGT) on subsequent comprehensive genomic profiling (CGP) success in community oncology practice for advanced non-small cell lung cancer (NSCLC): Results from a prospective observational reference laboratory testing program

被引：0
|
作者：
Nesline, Mary K.
DePietro, Paul
Cooper, Maureen
Zhang, Shengle
Howarth, Sarah
Wallen, Zachary D.
Biorn, Michael D.
Strickland, Kyle C.
Previs, Rebecca A.
Ko, Heidi Chwan
Sausen, Mark
Jackson, Jennifer B.
Saini, Kamal S.
Wise, Scott
Jensen, Taylor J.
Pabla, Sarabjot
Conroy, Jeffrey M.
Reddy, Prasanth
Severson, Eric A.
Ramkissoon, Shakti
机构：
[1] Labcorp Oncol, Durham, NC USA
[2] Labcorp Oncol, Buffalo, NY USA
[3] Labcorp, Buffalo, NY USA
[4] Duke Univ, Duke Canc Inst, Dept Pathol, Med Ctr, Durham, NC USA
[5] Duke Univ, Duke Canc Inst, Div Gynecol Oncol, Dept Obstet & Gynecol,Med Ctr, Durham, NC USA
[6] Personal Genome Diagnost, Labcorp, Baltimore, MD USA
[7] LabCorp, Ann Arbor, MI USA
[8] OmniSeq, Labcorp, Buffalo, NY USA
[9] OmniSeq Inc, Labcorp, Buffalo, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6506
引用
收藏
页数：1
相关论文
共 35 条
  • [21] Correlation of various clinical, imaging and laboratory parameters with outcome in patients with metastatic non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICIs): Results from a prospective, observational, single institution study
    Rounis, K.
    Papadaki, C.
    Makrakis, D.
    Monastirioti, A.
    Vamvakas, L.
    Kalbakis, K.
    Mavroudis, D.
    Aggelaki, S.
    ANNALS OF ONCOLOGY, 2019, 30 : 61 - 61
  • [22] TREATMENT DECISIONS FOR ELDERLY PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) IN ITALIAN CLINICAL PRACTICE: RESULTS FROM THE RIGHT-3 PROJECT BY ITALIAN ASSOCIATION OF MEDICAL ONCOLOGY
    Maiello, Evaristo
    Barni, Sandro
    Ardizzoni, Andrea
    Cappuzzo, Federico
    Chiari, Rita
    Maranzano, Ernesto
    Novello, Silvia
    Bennati, Chiara
    Di Maio, Massimo
    Ori, Alessandra
    Rizzoli, Sara
    Crino, Lucio
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S402 - S402
  • [23] HEALTH AND BUDGET IMPACT OF LIQUID-BASED COMPREHENSIVE GENOMIC PROFILE TESTING (CGP) IN ADVANCE NON-SMALL CELL LUNG CANCER (ANSCLC) PATIENTS WITH INSUFFICIENT TISSUE, EXHAUSTED TISSUE SAMPLES AND OR INSUFFICIENT DNA IN TISSUE SAMPLES
    Patel, Y.
    Husereau, D.
    Leighl, N. B.
    Melosky, B.
    Nam, J.
    VALUE IN HEALTH, 2020, 23 : S687 - S687
  • [24] THE ECONOMIC IMPACT OF EARLY COMPREHENSIVE GENOMIC PROFILING AND TARGETED THERAPY FOR ADVANCED NON-SMALL CELL LUNG CANCER PATIENTS: REAL WORLD EVIDENCE FROM A BRAZILIAN PRIVATE HEALTHCARE PROVIDER DATABASE
    Brust, L.
    Lemos, G.
    Azevedo, R.
    Silva, M. P.
    Oliveira, F.
    Zingano, F.
    Carniato, R.
    Torres, A.
    VALUE IN HEALTH, 2024, 27 (12) : S135 - S136
  • [25] THE IMPACT OF TUMOR HISTOLOGY ON EFFECTIVENESS IN BEVACIZUMAB (BV) TREATED PATIENTS (PTS) WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): RESULTS FROM ARIES, A BV OBSERVATIONAL COHORT STUDY (OCS)
    Brahmer, J.
    Spigel, D.
    Garst, J. L.
    Jahanzeb, M.
    Vidaver, R. M.
    Beatty, S.
    Teng, S. L.
    Flick, E. D.
    Sing, A. P.
    Lynch, T. J., Jr.
    ANNALS OF ONCOLOGY, 2010, 21 : 142 - 143
  • [26] Gemcitabine and cisplatin (GC) ± subsequent maintenance therapy with single-agent gemcitabine in advanced non-small cell lung cancer (NSCLC):: Preliminary results of a randomized trial of the Central European Cooperative Oncology Group (CECOG).
    Krzakowski, M
    Wenczl, M
    Brodowicz, T
    Tzekova, V
    Ramlau, R
    Ghilezan, N
    Cucevic, B
    Ulsperger, E
    Zielinski, C
    Zwitter, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 633S - 633S
  • [27] ANAPLASTIC LYMPHOMA KINASE (ALK) GENE REARRANGEMENT IN NON-SMALL CELL LUNG CANCER (NSCLC): RESULTS OF THE FIRST INTERN ROUND ROBIN PANEL TESTING (8 INSTITUTES FROM GERMANY AND SWITZERLAND)
    von Laffert, M.
    Schirmacher, P.
    Kreipe, H.
    Buettner, R.
    Petersen, I.
    Jochum, W.
    Dietel, M.
    Hummel, M.
    ANNALS OF ONCOLOGY, 2012, 23 : 394 - 394
  • [28] Cancer cachexia syndrome in the prediction of outcome in patients with metastatic non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICIs): Results from a single-institution, prospective, observational study.
    Mavroudis, Dimitrios
    Rounis, Konstantinos
    Makrakis, Dimitrios
    Georgiou, Alexandra
    Galanakis, Nikolaos
    Papadaki, Chara
    Vamvakas, Lampros
    Tsigkas, Alexandros-Pantelis
    Kontogianni, Meropi
    Gioulbasanis, Ioannis
    Agelaki, Sofia
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [29] Economic impact of next-generation sequencing (NGS) versus single-gene testing modalities to detect genomic alterations (GAs) in metastatic non-small cell lung cancer (mNSCLC) in Asia
    Loong, H.
    Wong, C. K. H.
    Leung, L. K. S.
    Chan, C. P. K.
    Chang, A.
    Zhou, Z-Y.
    Tang, W.
    Gibbs, M.
    ANNALS OF ONCOLOGY, 2020, 31 : S1394 - S1395
  • [30] Economic impact of next generation sequencing vs sequential single-gene testing modalities to detect genomic alterations in metastatic non-small cell lung cancer using a decision analytic model.
    Pennell, Nathan A.
    Mutebi, Alex
    Zhou, Zheng-Yi
    Ricculli, Marie Louise
    Tang, Wenxi
    Wang, Helen
    Guerin, Annie
    Arnhart, Tom
    Culver, Kenneth W.
    Otterson, Gregory Alan
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
1234